2020 marked the twelfth anniversary of China’s Anti-Monopoly Law. Over the course of the past year, the Chinese authorities made it clear that they expect to be full participants in th...
Davis Polk partners Will Pearce and Louis Goldberg are delighted to be contributing editors of the updated edition of Getting the Deal Through: Private M&A 2021, a comprehensive overview ...
Since April 2018, the Hong Kong Stock Exchange has had a regime for listing innovative “new economy” companies with dual-class share structures, which represents a key step toward ope...
Since April 2018, the Hong Kong Stock Exchange has had a regime for listing biotech companies that have yet to record any revenue, which is an important first step towards opening up the ...
In addition to antitrust and other regulatory approvals, an increasing number of jurisdictions have now adopted FDI screening mechanisms. These aim to determine whether investments by for...
2019 marked the eleventh anniversary of China’s Anti-Monopoly Law, which takes several noteworthy steps to refine and streamline antitrust enforcement in China. The arrival of the first...
On January 13, 2020, the U.S. Treasury Department promulgated its final regulations implementing the Foreign Investment Risk Review Modernization Act of 2018 (FIRRMA) to reform the author...
